The store will not work correctly when cookies are disabled.
6-(Cyclobutylmethoxy)-2,3-dihydrophthalazine-1,4-dione
ID: ALA5187187
PubChem CID: 168281078
Max Phase: Preclinical
Molecular Formula: C13H14N2O3
Molecular Weight: 246.27
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH][nH]c(=O)c2cc(OCC3CCC3)ccc12
Standard InChI: InChI=1S/C13H14N2O3/c16-12-10-5-4-9(18-7-8-2-1-3-8)6-11(10)13(17)15-14-12/h4-6,8H,1-3,7H2,(H,14,16)(H,15,17)
Standard InChI Key: MWPKIJXVHHDLCZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
0.1563 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8709 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5827 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5827 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8726 -0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1563 -0.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2974 -0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0120 -0.4126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0120 0.4126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2974 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2974 1.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2974 -1.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5583 0.8247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2730 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9875 0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2012 1.6221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0120 1.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7984 0.6075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
9 8 1 0
10 9 1 0
3 10 1 0
10 11 2 0
7 12 2 0
1 13 1 0
13 14 1 0
14 15 1 0
16 15 1 0
16 17 1 0
18 17 1 0
15 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.27 | Molecular Weight (Monoisotopic): 246.1004 | AlogP: 1.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.95 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.10 | CX Basic pKa: ┄ | CX LogP: 1.18 | CX LogD: 1.11 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.86 | Np Likeness Score: -0.47 |
References
1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B, Korn P, Lehtiö L, Tabarrini O.. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15., 237 [PMID:35500474] [10.1016/j.ejmech.2022.114362] |